SULLIVAN EDDIE JOE (Chief Executive Officer) purchased 0.3% of their position (14K shares) of SAB BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $10.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/8/2022ACC: 0001209191-22-049168
DirectorOfficer10% Owner· Chief Executive Officer
Since Oct 2021
+14K
Net shares
Net buyer
$10.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
14K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14K
Price / share
$0.74
Trade value
$10.32K
% of position
0.3%
9/7/2022
5.22M→5.23M
Total
Net shares
+14K
Net value
$10.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/7/2022 | P · Purchase | +14K | $0.74 | $10.32K | 0.3% | 5.22M | 5.23M |
| Total | +14K | $10.32K | ||||||
Derivative Transactions0
No derivative transactions reported